Skip to main content
TipRanks
Go Ultimate75% OFF

NDT Pharmaceuticals (NDTP) Financial Statements

11 Followers

NDT Pharmaceuticals Financial Overview

NDT Pharmaceuticals's market cap is currently $9.80M. The company's EPS TTM is $-0.00; its P/E ratio is -10.82; NDT Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 24Dec 23
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00
Operating Income$ -16.69K$ -25.17K
EBITDA$ -16.69K$ 88.87K
Net Income$ -16.69K$ -79.03K
Balance Sheet
Cash & Short-Term Investments$ 647.00$ 647.00
Total Assets$ 142.97K$ 142.97K
Total Debt$ 0.00$ 0.00
Net Debt$ -647.00$ -647.00
Total Liabilities$ 58.49K$ 41.80K
Stockholders' Equity$ 84.48K$ 101.17K
Cash Flow
Free Cash Flow$ -17.76K$ -17.76K
Operating Cash Flow$ -17.76K$ -17.76K
Investing Cash Flow$ 0.00$ 0.00
Financing Cash Flow$ 17.76K$ 17.76K

Currency in USD

NDT Pharmaceuticals Earnings and Revenue History

-90K-60K-30K00 %0.4 %0.8 %1.2 %EarningsProfit Margin20232024RevenueEarningsProfit Margin

NDT Pharmaceuticals Liabilities to Assets

060K120K180K24 %30 %36 %42 %LiabilitiesLiabilities to Assets20232024AssetsLiabilitiesLiabilities to Assets

NDT Pharmaceuticals Cash Flow

-20K-10K010K20K20232024OperatingInvestingFinancing

NDT Pharmaceuticals Forecast EPS vs Actual EPS